FdaApplication
NDA 207970
Identifiers
- fda_app_no: NDA207970
Properties
| Property | Value |
|---|---|
| applicant_name | ACTAVIS LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC |
| application_type | NDA |
| approval_date | 2024-03-14 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CABAZITAXEL | CABAZITAXEL | 60MG/6ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION;INTRAVENOUS |
1 product